EUVIMEDEUVIMED entdecken
Crossref

Spotlight on Coenzyme Q10 in scopolamine-induced Alzheimer’s disease: oxidative stress/PI3K/AKT/GSK 3ß/CREB/BDNF/TrKB

Sally A Abuelezz iD, Nevien Hendawy iD

Journal of Pharmacy and Pharmacology · 2023

DOI: 10.1093/jpp/rgad048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2023. Verfasst von Sally A Abuelezz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacology Department, Faculty of Medicine, Ain-Shams University, Cairo, Egypt. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Alzheimer Disease. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 91 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Excess amyloid beta (Aβ) and oxidative stress (OS) are inextricable hallmarks of the neuronal damage associated Alzheimer’s disease. Aβ-induced cognitive and memory dysfunctions are mediated through different signalling pathways as phosphatidylinositol-3-kinase (PI3K) and their downstream intermediates including protein-kinase-B, known as Akt, glycogen-synthase-kinase-3β (GSK-3β), cAMP-response-element-binding-protein (CREB), brain-derived-neurotrophic factor (BDNF) and tropomyosin-related-kinase receptor-B (TrKB). The current work aims to investigate the protective potentials of CoQ10 against scopolamine (Scop)-induced cognitive disability and the contribution of PI3K/Akt/GSK-3β/CREB/BDNF/TrKB in the neuroprotection effects.

Methods

The chronic co-administration of CQ10 (50, 100 and 200 mg/kg/day i.p.) with Scop in Wistar rats for 6 weeks were assayed both behaviourally and biochemically. Key findings CoQ10 ameliorated the Scop-induced cognitive and memory defects by restoring alterations in novel object recognition and Morris water maze behavioural tests. CoQ10 favourably changed the Scop-induced deleterious effects in hippocampal malondialdehyde, 8-hydroxy-2ʹ deoxyguanosine, antioxidants and PI3K/Akt/GSK-3β/CREB/BDNF/TrKB levels.

Conclusions

These results exhibited the neuroprotective effects of CoQ10 on Scop-induced AD and revealed its ability to inhibit oxidative stress, amyloid deposition and to modulate PI3K/Akt/GSK-3β/CREB/BDNF/TrKB pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-aktAlzheimer DiseaseRatsAnimalsGlycogen Synthase Kinase 3 betaPhosphatidylinositol 3-KinasesTropomyosinAmyloid beta-PeptidesPhosphatidylinositol 3-KinaseBrain-Derived Neurotrophic FactorRats, WistarOxidative StressScopolamine DerivativesUbiquinone

Stichwörter der Autor:innen

Coenzyme Q10amyloid-βbrain-derived neurotrophic factorglycogen-synthase-kinase-3βphosphatidylinositol-3-kinase/Akt

Substanzen

Proto-Oncogene Proteins c-aktGlycogen Synthase Kinase 3 betaPhosphatidylinositol 3-KinasesTropomyosinAmyloid beta-PeptidesPhosphatidylinositol 3-KinaseBrain-Derived Neurotrophic FactorScopolamine Derivativescoenzyme Q10Ubiquinone

Autor:innen und Institutionen

  • Clinical Pharmacology Department, Faculty of Medicine, Ain-Shams University, Cairo, Egypt.
  • Basic Medical Sciences Department, Faculty of Medicine, Faculty of Medicine, Galala University, Suez, Egypt.

ORCID-Profile: Sally A Abuelezz, Nevien Hendawy

Zitieren

APA

Abuelezz, S. A., & Hendawy, N. (2023). Spotlight on Coenzyme Q10 in scopolamine-induced Alzheimer’s disease: oxidative stress/PI3K/AKT/GSK 3ß/CREB/BDNF/TrKB. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgad048

Vancouver

Abuelezz SA, Hendawy N. Spotlight on Coenzyme Q10 in scopolamine-induced Alzheimer’s disease: oxidative stress/PI3K/AKT/GSK 3ß/CREB/BDNF/TrKB. Journal of Pharmacy and Pharmacology. 2023. doi:10.1093/jpp/rgad048

BibTeX
@article{Abuelezz2023,
  author = {Abuelezz, Sally A and Hendawy, Nevien},
  title = {Spotlight on Coenzyme Q10 in scopolamine-induced Alzheimer’s disease: oxidative stress/PI3K/AKT/GSK 3ß/CREB/BDNF/TrKB},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2023},
  doi = {10.1093/jpp/rgad048}
}
Kostenlos starten →